PCK 3.33% 3.1¢ painchek ltd

I agree with you 100% on all the points.I'm just saying there is...

  1. 2,241 Posts.
    lightbulb Created with Sketch. 486
    I agree with you 100% on all the points.

    I'm just saying there is not a 1:1 direct relationship between downloads and revenue, but i whole heartedly agree that it does show interest.

    Well, i'm not sure the moat would be a strong as you think. The risk is due to the vaccine roll out being so slow and lack of global progress, that PCK is leapfrogged by a business that has better luck with timing.

    The biggest issue is that it's just part of a solution, it's a not a solution on it's own. It also needs to be more prevalent to be a close to being considered a standard.

    Q3 is a big one, not only will we see who has taken up the option to extend past the 12 month trial, we will also see if Europe kick starts it's aged care programs and the Philips deal can make progress.

    Fingers crossed for PCK it's both
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $50.71M
Open High Low Value Volume
3.0¢ 3.1¢ 3.0¢ $23.71K 780.1K

Buyers (Bids)

No. Vol. Price($)
1 670001 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 512151 2
View Market Depth
Last trade - 16.10pm 08/05/2024 (20 minute delay) ?
Last
3.1¢
  Change
0.001 ( 6.90 %)
Open High Low Volume
3.0¢ 3.1¢ 3.0¢ 132340
Last updated 15.22pm 08/05/2024 ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.